
Private Equity · Patent Diligence
Operating Companies · Independent Assessment
With evidence instead of assumption - market differentiation, defensive positions, and leverage in competitive discussions.
Now used by the company and its outside prosecution counsel to expand into its highest-leverage growth areas.
The company had spent years and real money building its patent portfolio. What it didn't have was an independent answer to the question every board eventually asks: is any of this working?
Not “are we filing patents” - the invoices prove that. Whether the portfolio actually differentiates the company in its markets, deters the competitors it's supposed to deter, and creates leverage the business can use. When the only people grading the patent strategy are the people executing it, you don't have an assessment. You have an assumption.
We mapped every patent to the technologies and markets it actually covers, so the company could see its IP the way an acquirer, a competitor, or a licensing counterparty would - not the way the filing history happened to accumulate.
We evaluated the portfolios of competitors, suppliers, customers, and other industry participants across every vertical the company operates in - patent quality, technology coverage, market relevance, citation activity, and competitive positioning.
We identified patents held by others that could pose enforcement risk, constrain the company's portfolio expansion, or signal technologically disruptive activity headed its way.
Same question, different portfolio? Thirty minutes is enough to find out.
Book a CallThe assessment validated the strategy - with evidence instead of assumption. The portfolio supports market differentiation, provides significant defensive positions, creates leverage in competitive discussions, and carries pending applications that extend its life two decades out, along with real licensing and monetization potential.
Just as valuable was what the company got for the road ahead: a landscape report showing where the entire industry is investing in patents, and a white-space roadmap the company and its outside prosecution counsel are now using to expand the portfolio into its highest-leverage growth areas.
The Cost Of Waiting
Every year a portfolio goes unassessed is a year of prosecution budget spent on assumption - filings that may be reinforcing positions the company already holds while the white space goes to a competitor. Thirty minutes is enough to tell you whether your portfolio deserves the same independent look.
More Case Studies

Private Equity · Patent Diligence

Operating Companies · Portfolio Valuation

Investors & Lenders · Portfolio Assessment

Operating Companies · Patent Mining

Operating Companies · Litigation Finance